Guangdong Hengrui Pharmaceutical Co., Ltd
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Guangdong Hengrui Pharmaceutical Co., Ltd
RECRUITINGPhase 2NCT07233655
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
This study is ongoing to explore the efficacy and safety of different strengths of SHR-3045 injection in moderate to severe active rheumatoid arthritis.
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 301 location
Moderate to Severe Active Rheumatoid Arthritis
RECRUITINGPhase 2 / Phase 3NCT05979051
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis...
This study is a phase 2/3 clinical trial to evaluate the efficacy and safety of SHR-1703 in patients with EGPA.
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 1662 locations
Eosinophilic Granulomatosis With Polyangiitis
RECRUITINGPhase 2NCT07192939
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of...
To evaluate the efficacy and safety of HRS-9813 in subjects with pulmonary fibrosis。
Sponsor: Guangdong Hengrui Pharmaceutical Co., LtdEnrolling: 2701 location
IPF and PPF